ASTS stock · BMRN stock

ASTS vs BMRN · rev $4.4M vs P/E 40, rev $2.85B

Ast Spacemobile Inc (ASTS) versus Biomarin Pharmaceutical Inc (BMRN) — a side-by-side from cached financials, not a winner call.

Ast Spacemobile Inc (ASTS) is a communication equipment company listed on NASDAQ.

Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.

Latest reported ASTS revenue for 2024-12-31 was $4.4M. Net income was -$526.3M. ASTS currently screens at market cap $33.16B.

Latest reported BMRN revenue for 2024-12-31 was $2.85B. Net income was $426.9M. Revenue was up 18.0% from 2023-12-31 to 2024-12-31. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.

ASTS currently screens at market cap $33.16B. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.

Not investment advice. Open the ASTS and BMRN stock pages for the full models.

Not investment advice.

Popular Stock Comparisons